K
Kayitesi Kayitenkore
Researcher at Emory University
Publications - 20
Citations - 2296
Kayitesi Kayitenkore is an academic researcher from Emory University. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Condom. The author has an hindex of 15, co-authored 19 publications receiving 2104 citations.
Papers
More filters
Journal ArticleDOI
New heterosexually transmitted HIV infections in married or cohabiting couples in urban Zambia and Rwanda: an analysis of survey and clinical data
Kristin Dunkle,Rob Stephenson,Etienne Karita,Elwyn Chomba,Kayitesi Kayitenkore,Cheswa Vwalika,Lauren Greenberg,Susan Allen +7 more
TL;DR: Since most heterosexual HIV transmission for both men and women in urban Zambia and Rwanda takes place within marriage or cohabitation, voluntary counselling and testing for couples should be promoted, as should other evidence-based interventions that target heterosexual couples.
Journal ArticleDOI
Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2.
Connie Celum,Anna Wald,Anna Wald,J.R. Lingappa,Amalia Magaret,Amalia Magaret,Richard S. Wang,Nelly Mugo,Nelly Mugo,Andrew Mujugira,Jared M. Baeten,James I. Mullins,James P. Hughes,Elizabeth A. Bukusi,Elizabeth A. Bukusi,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,James Kiarie,Carey Farquhar,Grace John Stewart,Joseph Makhema,Myron Essex,Edwin Were,Kenneth H. Fife,G de Bruyn,Glenda Gray,James McIntyre,Rachel Manongi,Saidi Kapiga,David Coetzee,Susan Allen,Mubiana Inambao,Kayitesi Kayitenkore,Etienne Karita,William Kanweka,Sinead Delany,Helen Rees,Bellington Vwalika,Wendy S. Stevens,Campbell,Katherine K. Thomas,Robert W. Coombs,Rhoda Ashley Morrow,William L. H. Whittington,M J McElrath,M J McElrath,Linda E Barnes,Renee Ridzon,Lawrence Corey,Lawrence Corey +51 more
TL;DR: Daily acyclovir therapy did not reduce the risk of transmission of HIV-1, despite a reduction in plasma HIV- 1 RNA of 0.25 log(10) copies per milliliter and a 73% reduction in the occurrence of genital ulcers due to HSV-2.
Journal ArticleDOI
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
Joris Hemelaar,Ramyiadarsini Elangovan,Jason Yun,Leslie Dickson-Tetteh,Isabella Fleminger,Shona Kirtley,Brian G. Williams,Eleanor Gouws-Williams,Peter D. Ghys,Alash'le Abimiku,Simon Agwale,Chris P. Archibald,Boaz Avidor,María Gabriela Barbás,Françoise Barré-Sinoussi,Banson Barugahare,El Hadj Belabbes,Silvia Bertagnolio,Deborah L. Birx,Aleksei F Bobkov,James Brandful,Helba Bredell,Catherine A. Brennan,James Brooks,Marie Bruckova,Luigi Buonaguro,Franco M. Buonaguro,Stefano Buttò,Anne Buvé,Mary S. Campbell,Jean K. Carr,Alex Carrera,Manuel Gómez Carrillo,Connie Celum,Beth Chaplin,Macarthur Charles,Dimitrios Chatzidimitriou,Zhiwei Chen,Katsumi Chijiwa,David Cooper,Philip Cunningham,Anoumou Y. Dagnra,Cillian De Gascun,Julia del Amo,Elena Delgado,Ursula Dietrich,Dominic M. Dwyer,Dennis Ellenberger,Barbara Ensoli,Max Essex,Feng Gao,Hervé Fleury,Peter N. Fonjungo,Vincent Foulongne,Deepak A Gadkari,Federico García,Roger Garsia,Guy Michel Gershy-Damet,Judith R. Glynn,Ruth Goodall,Zehava Grossman,Monick Lindenmeyer-Guimarães,Beatrice H. Hahn,Raph L. Hamers,Osamah Hamouda,Ray Handema,Xiang He,Joshua T. Herbeck,David D. Ho,África Holguín,Mina C. Hosseinipour,Gillian Hunt,Masahiko Ito,Mohamed Ali Bel Hadj Kacem,Erin M. Kahle,Pontiano Kaleebu,Marcia L. Kalish,Adeeba Kamarulzaman,Chun Kang,Phyllis J. Kanki,Edward Karamov,Jean-Claude Karasi,Kayitesi Kayitenkore,Tony Kelleher,Dwip Kitayaporn,Leondios G. Kostrikis,Claudia Kücherer,Claudia Lara,Thomas Leitner,Kirsi Liitsola,J.R. Lingappa,Marek Linka,Ivette Lorenzana de Rivera,Vladimir Lukashov,Shlomo Maayan,Luzia Mayr,Francine E. McCutchan,Nicolas Meda,Elisabeth Menu,Fred Mhalu,Doreen Mloka,John L. Mokili,Brigitte Montes,Orna Mor,Mariza G. Morgado,Fausta Mosha,Awatef Moussi,James I. Mullins,Rafael Nájera,Mejda Nasr,Nicaise Ndembi,Joel R. Neilson,Vivek R. Nerurkar,Florian Neuhann,Claudine Nolte,Vlad Novitsky,Philippe Nyambi,Marianna Ofner,Fem J Paladin,Anna Papa,Jean Pape,Neil Parkin,Christopher M. Parry,Martine Peeters,Alexandra Pelletier,Lucía Pérez-Álvarez,Deenan Pillay,Angie N Pinto,Trinh Duy Quang,Cecilia Rademeyer,Filimone Raikanikoda,Mark A. Rayfield,Jean-Marc Reynes,Tobias F. Rinke de Wit,Kenneth E. Robbins,Morgane Rolland,Christine Rousseau,Jesus Salazar-Gonzales,Hanan Salem,Mika Salminen,Horacio Salomon,Paul Sandstrom,Mario L. Santiago,Abdoulaye Dieng Sarr,Bryan Schroeder,Michel Segondy,Philippe Selhorst,Sylvester Sempala,Jean Servais,Ansari Shaik,Yiming Shao,Amine Slim,Marcelo A. Soares,Elijah M. Songok,Debbie Stewart,Julie Stokes,Shambavi Subbarao,Ruengpung Sutthent,Jun Takehisa,Amilcar Tanuri,Kok Keng Tee,Kiran Thapa,Michael M. Thomson,Tyna Tran,Willy Urassa,Hiroshi Ushijima,Philippe Van de Perre,Guido van der Groen,Kristel Van Laethem,Joep J. van Oosterhout,Ard van Sighem,Eric Van Wijngaerden,Anne-Mieke Vandamme,Jurgen Vercauteren,Nicole Vidal,Lesley Wallace,Carolyn Williamson,Dawit Wolday,Jianqing Xu,Chunfu Yang,Linqi Zhang,Rong Zhang +181 more
TL;DR: The distribution of HIV-1 subtypes and recombinants changed over time in countries, regions, and globally as well as at a global level during 2005-15, where subtype B increased, subtypes A and D were stable, and subtypes C and G and CRF02_AG decreased.
Journal ArticleDOI
CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa
Etienne Karita,Nzeera Ketter,Matthew Price,Kayitesi Kayitenkore,Pontiano Kaleebu,Annet Nanvubya,Omu Anzala,Walter Jaoko,Gaudensia Mutua,Eugene Ruzagira,Joseph Mulenga,Eduard J. Sanders,Eduard J. Sanders,Mary Mwangome,Susan Allen,Agnes N. Bwanika,Ubaldo Bahemuka,Ken Awuondo,Gloria Omosa,Bashir Farah,Pauli N. Amornkul,Josephine Birungi,Sarah Yates,Lisa Stoll-Johnson,J Gilmour,Gwynn Stevens,Erin Shutes,Olivier Manigart,Peter Hughes,Len Dally,Janet T Scott,Wendy S. Stevens,Pat Fast,Anatoli Kamali +33 more
TL;DR: Establishing clinical laboratory reference intervals for 25 hematology, immunology and biochemistry values among healthy African adults typical of those who might join a clinical trial provides ranges that will inform inclusion criteria and evaluation of adverse events for studies in these regions of Africa.
Journal ArticleDOI
Daily aciclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial.
Jairam R. Lingappa,Jared Baeten,Anna Wald,James P. Hughes,Katherine K Thomas,Andrew Mujugira,Nelly Mugo,Elizabeth A. Bukusi,Elizabeth A. Bukusi,Craig R. Cohen,Elly Katabira,Allan R. Ronald,James Kiarie,Carey Farquhar,Grace John Stewart,Joseph Makhema,Myron Essex,Edwin Were,Kenneth H. Fife,Guy de Bruyn,Glenda Gray,James McIntyre,Rachel Manongi,Saidi Kapiga,David Coetzee,Susan Allen,Mubiana Inambao,Kayitesi Kayitenkore,Etienne Karita,William Kanweka,Sinead Delany,Helen Rees,Bellington Vwalika,Amalia Magaret,Amalia Magaret,Richard S. Wang,Lara Kidoguchi,Linda E Barnes,Renee Ridzon,Lawrence Corey,Lawrence Corey,Lawrence Corey,Connie Celum +42 more
TL;DR: The role of suppression of herpes simplex virus type 2 in reduction of HIV-1 disease progression before initiation of antiretroviral therapy warrants consideration.